TEOSYAL®

About TEOSYAL® — Swiss RHA® and PURESENSE Dermal Fillers

TEOSYAL® is manufactured by Teoxane Laboratories in Geneva, Switzerland. Teoxane has built its portfolio of injectable dermal fillers around non-animal hyaluronic acid and treatment-specific gel properties, and the company is one of the few manufacturers that developed its dynamic-expression filler technology in close partnership with dermatologists from the outset.

The TEOSYAL® range can be sorted into two families:

• TEOSYAL RHA®: Resilient Hyaluronic Acid fillers designed for areas exposed to repeated facial movements and expressions. RHA® is cross-linked HA engineered to deform under the stress of facial expression and then recover its shape, reducing palpability and displacement risk in dynamic areas compared to standard cross-linked HA.
• TEOSYAL PURESENSE: These HA dermal fillers contain lidocaine, with formulations ranging from skin revitalization to deep structural volumizing.

In the US market, Teoxane partners with Revance Therapeutics to distribute the FDA-approved RHA® Collection, which integrates lidocaine or mepivacaine directly into its formulations. The European PURESENSE line maintains separate branding for its anesthetic-containing versions.

For practitioners deciding which TEOSYAL® filler to stock, the distinction between product families is not simply about HA concentration. Product elasticity, gel strength, injection depth, the degree of facial movement at the treatment site, and the desired correction all matter when selecting a formulation. Clinics that buy TEOSYAL® wholesale and need to cover multiple treatment areas will often carry products from both families for precisely this reason.

TEOSYAL RHA® Range

The RHA® family is designed around different levels of flexibility and structural support. Practitioners looking to purchase TEOSYAL® can select the formulation based on treatment depth and the amount of movement in the target area.

TEOSYAL® RHA KISS

RHA KISS is designed for the lips and perioral region, where flexibility is particularly important during speaking, smiling, and other facial movements. It provides lip definition and volume while maintaining a softer dynamic profile. This product is available in CE-marked regions (Europe, UK, Canada) as a distinct 0.7 ml syringe and is not sold under this name in the US market, where lip treatment typically falls under other RHA® products and their respective FDA clearances.

TEOSYAL® RHA1

RHA1 is one of the lightest products in the range, suited to fine superficial lines and areas where a lower-viscosity gel is appropriate. In the US, RHA1 is FDA-approved for dynamic perioral rhytids. [1]

TEOSYAL® RHA2

RHA2 is intended for moderate dynamic wrinkles and folds. It handles areas requiring more correction than RHA1 while still maintaining flexibility during facial expression.

TEOSYAL® RHA3

RHA3 offers greater structural support for deeper wrinkles and folds. It is commonly used to treat moderate-to-severe nasolabial folds and is also FDA-approved for lip augmentation based on recent clinical data. [1]

TEOSYAL® RHA4

RHA4 is the most structurally supportive formulation in the traditional RHA® group, used for deeper facial contours and areas requiring projection, support, or volume restoration.

TEOSYAL® PURESENSE Range

The PURESENSE family covers a broader range of indications, from superficial rejuvenation and lip enhancement to tear-trough correction and deep facial volume. This variety also gives practitioners who buy TEOSYAL® products greater flexibility to select formulations based on the treatment area, desired correction, and injection depth.

TEOSYAL® PURESENSE DEEP LINES

PURESENSE DEEP LINES is designed for deeper wrinkles and deep lines, including nasolabial folds. The formulation contains lidocaine to support treatment comfort.

TEOSYAL® PURESENSE GLOBAL ACTION

GLOBAL ACTION provides a more versatile option for facial lines, mild volume correction, and broader rejuvenation. It sits between superficial skin-quality products and deeper volumizers in the PURESENSE range.

TEOSYAL® PURESENSE KISS

Known as the dedicated TEOSYAL® lip filler, PURESENSE KISS is formulated for volume, contour, and definition. It contains lidocaine and can be selected when practitioners want a lip-specific gel outside the RHA® family. It plumps and hydrates the lips while providing shape that meets patient expectations.

TEOSYAL® PURESENSE REDENSITY I

REDENSITY I is designed as a skin booster TEOSYAL® treatment for revitalization and hydration rather than deep structural correction. It is available in different pack formats, including 1 x 3 mL and 2 x 1 mL, allowing practitioners to select the format that best suits their treatment planning.

TEOSYAL® PURESENSE REDENSITY II

REDENSITY II is specifically designed for the delicate under-eye region, targeting correction of under-eye hollows, dark circles, and fine lines. Real-world clinical research has evaluated its use and safety across the periorbital area. [3] For practitioners looking for the right TEOSYAL® filler for under-eye areas, REDENSITY II occupies a distinct place in the range because its rheology and intended treatment area differ from those of conventional volumizing fillers.

TEOSYAL® PURESENSE ULTIMATE

TEOSYAL® PureSense Ultimate lidocaine is intended for deep volumizing and facial contouring. Select it for areas requiring stronger projection and structural support, including the cheeks, chin, and jawline.

TEOSYAL® PURESENSE ULTRA DEEP

ULTRA DEEP is designed for deeper placement and maximum-depth facial contour restoration, including augmentation and correction of deeper folds in thicker tissue areas.

Full TEOSYAL® Product Range

• TEOSYAL® RHA1: flexible HA for fine superficial lines
• TEOSYAL® RHA2: moderate wrinkles and dynamic folds
• TEOSYAL® RHA3: deeper wrinkles, folds, and lip augmentation
• TEOSYAL® RHA4: stronger structural support and deep correction
• TEOSYAL® RHA KISS: flexible lip-focused RHA® filler (CE-marked regions)
• TEOSYAL® PURESENSE KISS: lip volume and definition with lidocaine
• TEOSYAL® PURESENSE DEEP LINES: deeper facial wrinkles and folds
• TEOSYAL® PURESENSE GLOBAL ACTION: multi-area facial correction
• TEOSYAL® PURESENSE ULTIMATE: deep facial volumizing
• TEOSYAL® PURESENSE ULTRA DEEP: structural contour and volume
• TEOSYAL® PURESENSE REDENSITY I (1x3ml and 2x1ml): skin revitalization
• TEOSYAL® PURESENSE REDENSITY II (2x1ml): under-eye and tear-trough treatment

Additional or legacy presentations may include:

• TEOSYAL® KISS without lidocaine
• TEOSYAL® DEEP LINES without lidocaine
• TEOSYAL® GLOBAL ACTION without lidocaine
• TEOSYAL® MESO: mesotherapy-grade HA skin hydration
• TEOSYAL® REDENSITY [1]: skin booster (no lidocaine)
• TEOSYAL® REDENSITY [2]: tear trough (no lidocaine)
• TEOSYAL® ULTIMATE: deep volumizer (no lidocaine)
• TEOSYAL® ULTRA DEEP: maximum depth (no lidocaine)

Current Teoxane documentation also reflects newer RHA-branded products in selected markets, including RHA Redensity, RHA Redensity Eye, and RHA Dynamic Volume. Product names, anesthetic formulations, and indications may differ by jurisdiction. Practitioners should confirm the current Medical Spa Rx inventory before ordering TEOSYAL® online.

Treatment Areas

The vast TEOSYAL® range allows selection based on facial anatomy and treatment objectives rather than defaulting to a single filler across all indications.

Lips

PURESENSE KISS and RHA KISS are intended for lip-focused treatment. Depending on the product selected, practitioners can address volume, contour, definition, and perioral correction while accounting for the high degree of movement in this area. TEOSYAL® before and after outcomes in the lip area highlight how the RHA® flexibility translates to results that look natural during speech and expression.

Cheeks and Facial Contours

RHA3, RHA4, PURESENSE ULTIMATE, and ULTRA DEEP offer progressively stronger options for deeper correction and structural support in areas such as the cheeks, chin, and jawline. RHA Dynamic Volume also provides an FDA-approved option specifically for cheek augmentation and midface contour loss.

Under-Eye Area

PURESENSE REDENSITY II is designed specifically for under-eye hollows and the tear trough. Teoxane identifies REDENSITY II as a dedicated HA formulation for this delicate anatomical region.

Skin Quality

PURESENSE REDENSITY I acts as a skin booster rather than a conventional volumizing filler, targeting hydration, texture, elasticity, and broader biorevitalization.

Fine Lines and Wrinkles

RHA1, RHA2, PURESENSE DEEP LINES, and GLOBAL ACTION provide different levels of correction to soften the appearance of fine lines and wrinkles. Product choice depends on wrinkle depth, facial movement, tissue thickness, and the required level of support.

FDA Approval and Regulatory Status of TEOSYAL®

TEOSYAL® regulatory status varies by product and market, so practitioners should verify the individual SKU before use.

In the United States, Teoxane partners with Revance Therapeutics to distribute the FDA-approved RHA® Collection. The original PMA for the RHA® family was approved on October 19, 2017, covering RHA2 and RHA3 for moderate-to-severe dynamic facial wrinkles and folds, and RHA4 for deeper placement in the treatment of comparable dynamic folds. [1]

The US portfolio has expanded substantially since then. FDA records now include:

• RHA1 for dynamic perioral rhytids [1]
• RHA3 for lip augmentation [1]
• RHA Redensity for dynamic perioral rhytids [1]
• RHA Redensity Eye for infraorbital volume deficiency [5]
• RHA Dynamic Volume for cheek augmentation and age-related midface contour deficiencies [2]

The RHA® Collection carries individual FDA approvals for specific indications, while many international PURESENSE presentations are not part of the same US approval set.

In Europe, Teoxane announced MDR certification for its TEOSYAL® PureSense and TEOSYAL RHA® portfolio in 2023. [4] The full range of dermal fillers is CE-marked for the European and UK markets.

Practitioners should check the precise product, indication, formulation, and jurisdiction before treatment.

How Long Does TEOSYAL® Filler Last?

Longevity depends heavily on the formulation, injection site, amount used, tissue movement, metabolism, and treatment objective.

Current Teoxane product information provides approximate in vivo durations that vary across the range.

• RHA2, RHA3, and RHA4: approximately 12 to 15 months
• RHA KISS and RHA1: approximately 6 to 9 months
• PURESENSE ULTIMATE: approximately 12 to 18 months
• PURESENSE REDENSITY II: approximately 9 to 12 months
• PURESENSE REDENSITY I skin booster: approximately 6 months

Professionals must treat these figures as product guidance, not guarantees. Facial movement, TEOSYAL® injection technique, volume placed, anatomy, and individual HA metabolism can all influence duration. Because these products are based on hyaluronic acid (HA), correction may also be managed with hyaluronidase when clinically appropriate.

TEOSYAL® Compared to Other HA Fillers

Practitioners deciding whether to order TEOSYAL® online will often compare it with other established HA filler families. The useful comparison is not which brand is universally better, but how the technology, range, and available formulations align with the treatment goal. TEOSYAL® dermal filler reviews from practitioners tend to focus on the RHA® flexibility advantage in dynamic zones, where the most meaningful competitive differences emerge.

vs JUVÉDERM®

JUVÉDERM® VYCROSS® gels are favored for their longevity in the mid-face, with some products maintaining correction for 18 to 24 months. TEOSYAL RHA® takes a different approach, engineering flexibility into the gel so that it adapts to facial movement rather than prioritizing raw duration. For lip treatment, JUVÉDERM® Volbella and Ultra Smile compete with TEOSYAL® KISS and RHA KISS, with RHA KISS specifically adding expression-area flexibility. JUVÉDERM® currently holds a broader FDA indication set in the US.

vs Restylane®

Restylane® XpresHAn Technology™ and TEOSYAL RHA® share the same design premise: HA gels that accommodate dynamic facial expression. That makes this a technology comparison rather than a category comparison. The two ranges diverge in specialized products. Restylane® EYELIGHT™ competes with REDENSITY II in the under-eye space, and REDENSITY II is one of the most studied European tear trough fillers in the published literature. [3] Restylane® SKINBOOSTERS™ and PURESENSE REDENSITY I target comparable skin-quality indications with similar HA content. Restylane® holds more FDA approvals overall, including LYFT, KYSSE, DEFYNE, and REFYNE.

vs BELOTERO®

BELOTERO® CPM technology is engineered for even tissue integration and is widely considered the strongest option for superficial fine lines where Tyndall effect risk must be minimized. TEOSYAL® RHA1 and PURESENSE DEEP LINES address similar superficial indications through a different mechanism. At the deeper end, BELOTERO® Intense and Volume are the range’s most structural products but are not RHA-engineered for dynamic movement. BELOTERO® also lacks a dedicated tear trough product to match REDENSITY II.

vs REVANESSE®

REVANESSE® is positioned on tolerability, with relatively low post-treatment swelling. REVANESSE® LIPS+ competes most directly with Teosyal® KISS in the lip segment. The REVANESSE® catalog is more compact, however, with no dedicated tear trough filler, no skin booster equivalent, and no dynamic movement-specific technology comparable to RHA®. It is competitively priced in wholesale channels.

vs STYLAGE®

STYLAGE® IPN-Like cross-linking incorporates mannitol, an antioxidant that is intended to reduce post-injection edema and extend HA longevity by neutralizing free radicals in treated tissue. STYLAGE® does not include an RHA®-equivalent dynamic technology. For lip filler, STYLAGE® Special Lips and Teosyal® KISS both carry CE marking, and no head-to-head randomized controlled trial establishes a clear advantage for either. Teosyal® holds stronger FDA registration, while STYLAGE® is primarily a European-market range.

Side Effects and Safety

As with other injectable HA fillers, TEOSYAL® can cause temporary injection-site reactions. Common effects may include swelling, bruising, redness, tenderness, local discomfort, and temporary firmness or papules. These are typically transient and resolve within several days.

Less common complications can include nodules, persistent asymmetry, inflammatory reactions, and infection. The most serious potential side effects of TEOSYAL®, as with any dermal filler, relate to inadvertent vascular injection or vascular occlusion. Although rare, vascular compromise can cause tissue injury and requires immediate recognition and management by a trained practitioner.

TEOSYAL RHA® fillers are designed to adapt to facial movement, which can help reduce displacement and palpability in dynamic treatment areas compared to more rigid HA formulations. Because TEOSYAL® is an HA-based product, hyaluronidase may be used when clinically indicated to dissolve or reduce the product.

The side effects of TEOSYAL® therefore depend not only on the formulation itself but also on anatomy, injection plane, technique, volume, and practitioner experience. Practitioners should review the patient’s medical history, current medications, allergies, previous aesthetic procedures, and any existing filler in the intended treatment area before every TEOSYAL® injection.

Where to Buy TEOSYAL® Online at Wholesale Prices

Medical Spa Rx provides a professional platform for licensed aesthetic practitioners looking to buy TEOSYAL® wholesale or compare products across the RHA® and PURESENSE families. We carry both product families so that practitioners can evaluate TEOSYAL® price per unit and TEOSYAL® cost across formulations from one platform rather than sourcing from multiple distributors.

Practices can buy TEOSYAL® online with access to wholesale pricing, volume-based savings, and verified product sourcing. Medical Spa Rx also offers a price-beat program, no minimum order requirement, and free shipping on qualifying orders over $1,000. Every order includes:

• Authentic products with verifiable LOT numbers
• Wholesale pricing and volume savings
• 24-hour professional license verification
• Fully tracked fulfillment
• A 14-day delivery guarantee
• Temperature-controlled shipping where required
• Dedicated account support

Practitioners ready to buy TEOSYAL® wholesale can compare available formulations before placing an order, while those who need a smaller selection can purchase TEOSYAL® online according to current treatment demand. Whether your practice needs TEOSYAL® RHA filler products for dynamic areas, REDENSITY for skin or under-eye protocols, or PURESENSE volumizers, Medical Spa Rx provides a straightforward way to order TEOSYAL® online and manage professional filler inventory.

Frequently Asked Questions

What is TEOSYAL®?

TEOSYAL® is a Swiss hyaluronic acid dermal filler range developed by Teoxane Laboratories. It includes the RHA® family for dynamic facial areas and the PURESENSE line for lips, under-eye correction, wrinkles, skin revitalization, and facial volume.

What is RHA® technology?

RHA® stands for Resilient Hyaluronic Acid. The technology provides correction while retaining flexibility in areas exposed to repeated facial movements, making it particularly relevant for dynamic facial wrinkles and folds. [2]

Is TEOSYAL® FDA-approved?

Selected RHA® products and indications are FDA-approved through Teoxane’s partnership with Revance Therapeutics, including RHA1, RHA2, RHA3, RHA4, RHA Redensity, RHA Redensity Eye, and RHA Dynamic Volume. The international TEOSYAL® PURESENSE catalog is CE-marked but is not covered by the US approval set.

How long does TEOSYAL® filler last?

Duration varies by formulation, treatment area, metabolism, and technique. Product-specific estimates range from approximately 6 months for lighter formulations like REDENSITY I up to 12 to 18 months for deeper volumizing products like PURESENSE ULTIMATE. All are reversible with hyaluronidase.

What is REDENSITY II used for?

REDENSITY II is a dedicated under-eye and tear trough filler designed for the delicate periorbital area. Clinical evidence has evaluated its effectiveness and safety across the wider under-eye region. [3]

Is TEOSYAL® a good filler?

TEOSYAL® is an established HA filler family with multiple treatment-specific formulations and clinical evidence supporting several products. Whether it is appropriate depends on the intended correction, treatment area, patient anatomy, regulatory status, and practitioner technique.

JUVÉDERM® vs TEOSYAL® – which is better?

Neither brand is universally better. JUVÉDERM® VYCROSS® gels are known for mid-face longevity, while TEOSYAL RHA® is specifically designed for areas where flexibility during facial movements matters most. Product selection should follow the specific indication and desired rheological properties.

Where can practitioners buy TEOSYAL® wholesale?

Licensed practitioners can buy TEOSYAL® wholesale through Medical Spa Rx, with professional pricing, LOT-verifiable products, tracked shipping, a price-beat program, no minimum order, and streamlined license verification.

Citations

[1] U.S. Food and Drug Administration. “PMA P170002: RHA 2, RHA 3, RHA 4.” Premarket Approval (PMA) Database, U.S. Food and Drug Administration, 19 Oct. 2017, https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P170002.

[2] Monheit, Gary et al. “Efficacy and Safety of Two Resilient Hyaluronic Acid Fillers in the Treatment of Moderate-to-Severe Nasolabial Folds: A 64-Week, Prospective, Multicenter, Controlled, Randomized, Double-Blinded, and Within-Subject Study.” Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] vol. 46,12 (2020): 1521-1529. doi:10.1097/DSS.0000000000002391

[3] Bhojani-Lynch, Tahera et al. “Real-World Evidence on the Routine Use, Efficacy, and Safety of a Hyaluronic Acid-Based Dermal Filler in the Periorbital Region.” Aesthetic plastic surgery vol. 49,15 (2025): 4392-4402. doi:10.1007/s00266-025-04809-9

[4] Teoxane. “Teoxane MDR Certification.” Teoxane, 1 June 2021, https://www.teoxane.com/en/newsroom/teoxane-mdr-certification.

[5] U.S. Food and Drug Administration. “PMA P170002/S050: RHA Redensity® Eye Lido; RHA Redensity® Eye.” Premarket Approval (PMA) Database, U.S. Food and Drug Administration, 12 May 2026, https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?ID=P170002S050.

The page and all its displayed content are for medical professionals, intended only to inform and not as a replacement for medical advice.

Related brands to TEOSYAL®

ALIAXIN®

BELLAST®

BELOTERO®

CAREGEN

CROMA